CD34 and myelodysplastic syndrome: In keeping with our results, no correlation between an IFN response in the bone marrow of CD34+ cells and the response to AZA and DAC was shown in a cohort of 55 patients with MDS and CMML, whereas, the inflammatory signaling was reduced instead of enhanced after HMA administration (88).